Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Swick, Michelle C ^a,e   Evangelista, Michael A ^a,b   Bodine, Truston J ^a   Easton Marks, Jeremy R ^a   Barth, Patrick ^a,b   Shah, Minita J ^c   Bormann Chung, Christina A ^d   Stanley, Sarah ^c   McLaughlin, Stephen F ^c   Lee, Clarence C ^c   Sheth, Vrunda ^c   Doan, Quynh ^d   Hamill, Richard J ^a   Steffen, David ^a   Becnel, Lauren B ^a   Sucgang, Richard ^b   Zechiedrich, Lynn ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Verna and Marrs McLean Department of Biochemistry and Molecular Biology   (United States)

^c Life Technologies   (United States)

^d Life Technologies Corporation   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINO ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOXITIN; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GATIFLOXACIN; GENOMIC DNA; GENTAMICIN; HYDROGEN PEROXIDE; IMIPENEM; LEUCINE; LEVOFLOXACIN; NITROFURANTOIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECG HELICASE; SERINE; TIMENTIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; QUINOLONE DERIVATIVE;

ALPHA HELIX; ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATION; DNA BINDING; DNA DAMAGE; DNA METABOLISM; DNA SEQUENCE; ESCHERICHIA COLI; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENE TECHNOLOGY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC COMPLEMENTATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; LIGB GENE; MULTIDRUG RESISTANCE; MUTM GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY ISLAND; PLASMID; RECG GENE; SINGLE NUCLEOTIDE POLYMORPHISM; DRUG EFFECTS; GENETICS; GENOTYPE; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; GENOTYPE; MICROBIAL SENSITIVITY TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84879140394     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065961     Document Type: Article

References (57)

1. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA, (2010) Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother 54: 109-115.
2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, et al. (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48: 1-12.
3. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, et al. (2007) Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 122: 160-166.
4. Peleg AY, Hooper DC, (2010) Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 362: 1804-1813.
5. Stone PW, Hedblom EC, Murphy DM, Miller SB, (2005) The economic impact of infection control: making the business case for increased infection control resources. Am J Infect Control 33: 542-547.
6. Nikaido H, (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78: 119-146.
7. Heisig P, (1996) Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 40: 879-885.
8. Morgan-Linnell SK, Zechiedrich L, (2007) Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 51: 4205-4208.
9. Singh R, Swick MC, Ledesma KR, Yang Z, Hu M, et al. (2012) Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother 56: 1680-1685.
10. Turner AK, Nair S, Wain J, (2006) The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 58: 733-740.
11. Everett MJ, Jin YF, Ricci V, Piddock LJ, (1996) Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40: 2380-2386.
12. Ruiz J, (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51: 1109-1117.
13. Yoshida H, Bogaki M, Nakamura M, Nakamura S, (1990) Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 34: 1271-1272.
14. Martinez-Martinez L, Pascual A, Jacoby GA, (1998) Quinolone resistance from a transferable plasmid. Lancet 351: 797-799.
15. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, et al. (2006) Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12: 83-88.
16. Tran JH, Jacoby GA, (2002) Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A 99: 5638-5642.
17. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, et al. (2003) Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47: 2242-2248.
18. Robicsek A, Jacoby GA, Hooper DC, (2006) The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6: 629-640.
19. Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H, (2000) High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 44: 3441-3443.
20. Becnel Boyd L, Maynard MJ, Morgan-Linnell SK, Horton LB, Sucgang R, et al. (2009) Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates. Antimicrob Agents Chemother 53: 229-234.
21. Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L, (2011) Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 55: 921-924.
22. Bush WS, Moore JH, (2012) Chapter 11: genome-wide association studies. PLoS Comput Biol 8: e1002822.
23. D'Costa VM, McGrann KM, Hughes DW, Wright GD, (2006) Sampling the antibiotic resistome. Science 311: 374-377.
24. Wright GD, (2007) The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol 5: 175-186.
25. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, et al. (2011) Rapid pneumococcal evolution in response to clinical interventions. Science 331: 430-434.
26. Davies J, Davies D, (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74: 417-433.
27. Fricke WF, Wright MS, Lindell AH, Harkins DM, Baker-Austin C, et al. (2008) Insights into the environmental resistance gene pool from the genome sequence of the multidrug-resistant environmental isolate Escherichia coli SMS-3-5. J Bacteriol 190: 6779-6794.
28. Boyd LB, Atmar RL, Randall GL, Hamill RJ, Steffen D, et al. (2008) Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis 8: 4.
29. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
30. Kaas RS, Friis C, Ussery DW, Aarestrup FM, (2012) Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes. BMC Genomics 13: 577.
31. Durfee T, Nelson R, Baldwin S, Plunkett G 3rd, Burland V, et al (2008) The complete genome sequence of Escherichia coli DH10B: insights into the biology of a laboratory workhorse. J Bacteriol 190: 2597-2606.
32. Jeong H, Barbe V, Lee CH, Vallenet D, Yu DS, et al. (2009) Genome sequences of Escherichia coli B strains REL606 and BL21(DE3). J Mol Biol 394: 644-652.
33. Barrick JE, Yu DS, Yoon SH, Jeong H, Oh TK, et al. (2009) Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461: 1243-1247.
34. Daegelen P, Studier FW, Lenski RE, Cure S, Kim JF, (2009) Tracing ancestors and relatives of Escherichia coli B, and the derivation of B strains REL606 and BL21(DE3). J Mol Biol 394: 634-643.
35. Sahl JW, Steinsland H, Redman JC, Angiuoli SV, Nataro JP, et al. (2011) A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation. Infect Immun 79: 950-960.
36. Keller I, Bensasson D, Nichols RA, (2007) Transition-transversion bias is not universal: a counter example from grasshopper pseudogenes. PLoS Genet 3: e22.
37. Zhang Z, Gerstein M, (2003) Patterns of nucleotide substitution, insertion and deletion in the human genome inferred from pseudogenes. Nucleic Acids Res 31: 5338-5348.
38. Coculescu BI, (2009) Antimicrobial resistance induced by genetic changes. J Med Life 2: 114-123.
39. Sutherland JH, Tse-Dinh YC, (2010) Analysis of RuvABC and RecG involvement in the Escherichia coli response to the covalent topoisomerase-DNA complex. J Bacteriol 192: 4445-4451.
40. Rudolph CJ, Upton AL, Harris L, Lloyd RG, (2009) Pathological replication in cells lacking RecG DNA translocase. Mol Microbiol 73: 352-366.
41. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, et al. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006 0008.
42. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ, (2007) Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol 3: 91.
43. Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC, (2012) Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336: 315-319.
44. Sriskanda V, Shuman S, (2001) A second NAD(+)-dependent DNA ligase (LigB) in Escherichia coli. Nucleic Acids Res 29: 4930-4934.
45. Lu T, Zhao X, Drlica K, (1999) Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group. Antimicrob Agents Chemother 43: 2969-2974.
46. Wang X, Kim Y, Ma Q, Hong SH, Pokusaeva K, et al. (2010) Cryptic prophages help bacteria cope with adverse environments. Nat Commun 1: 147.
47. Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MO, et al. (2012) The shared antibiotic resistome of soil bacteria and human pathogens. Science 337: 1107-1111.
48. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ, (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
49. Michaels ML, Miller JH, (1992) The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine). J Bacteriol 174: 6321-6325.
50. Orlen H, Hughes D, (2006) Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 50: 3454-3456.
51. Mandsberg LF, Macia MD, Bergmann KR, Christiansen LE, Alhede M, et al. (2011) Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM). FEMS Microbiol Lett 324: 28-37.
52. Wang K, Li M, Hakonarson H, (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38: e164.
53. de Hoon MJ, Imoto S, Nolan J, Miyano S, (2004) Open source clustering software. Bioinformatics 20: 1453-1454.
54. Huang W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
55. Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, et al. (2004) Versatile and open software for comparing large genomes. Genome Biol 5: R12.
56. Das R, Baker D, (2008) Macromolecular modeling with rosetta. Annu Rev Biochem 77: 363-382.
57. Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E, et al. (2005) Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res 12: 291-299.